Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular neridronate for complex regional pain syndrome type I
2014-001156-28Phase 3Completed
- Sponsor
- Abiogen Pharma
- Start
- Sep 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Complex Regional Pain Syndrome Type 1 (CRPS-1) comparing Nerixia with Placebo (2 arms). Primary endpoint: Pain responder rate at Day 30. Started Sep 2014; status: completed.
02
Drugs
neridronic acid
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2014-001156-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001156-28.